Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Intravenous Fluid Bags Market will Accelerate at a CAGR of over 6% through 2021-2025 | Widespread Availability And Affordability Of IV Fluid Bags to upheave Growth | Technavio


NEW YORK, May 13, 2021 /PRNewswire/ -- Set to grow by $ 2.38 bn during 2021-2025, Technavio's latest market research report estimates the intravenous fluid bags market to register a CAGR of over 6%. With a focus on identifying dominant industry influencers, Technavio's reports present a detailed study by the way of synthesis, and summation of data from multiple sources. This report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. Download Latest Free Sample Report 

The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Amcor Plc, B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi AG, ICU Medical Inc., JW Lifescience Corp., Merit Medical Systems Inc., PolyCine GmbH, Smiths Group Plc, and SSY Group Ltd. are some of the major market participants. The rising prevalence of chronic diseases, widespread availability and affordability of IV fluid bags, increasing use of disposable IV fluid bags will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Intravenous Fluid Bags Market 2021-2025: Segmentation
Intravenous Fluid Bags Market is segmented as below:

To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR40565

Intravenous Fluid Bags Market 2021-2025: Vendor Analysis and Scope
To help businesses improve their market position, the intravenous fluid bags market provides a detailed analysis of around 25 vendors operating in the market. Some of these vendors include Amcor Plc, B. Braun Melsungen AG, Baxter International Inc., Fresenius Kabi AG, ICU Medical Inc., JW Lifescience Corp., Merit Medical Systems Inc., PolyCine GmbH, Smiths Group Plc, and SSY Group Ltd.

The report also covers the following areas:

The use of multi-chambered IV fluid bags for parenteral nutrition is likely to emerge as one of the primary drivers of the market. However, factors such as risks associated with the use of IV fluid bags is may threaten the growth of the market.

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio's SUBSCRIPTION platform

Backed with competitive intelligence and benchmarking, our research reports on the intravenous fluid bags market are designed to provide entry support, customer profile & M&As as well as go-to-market strategy support.

Related Reports on Health Care Include:

Medical Gas Equipment Market by End-user and Geography - Forecast and Analysis 2021-2025: The medical gas equipment market size is expected to grow by USD 3.79 billion and record a decelerating CAGR of 10.82% during 2021-2025, according to Technavio. Download Free Sample

Alcohol Prep Pads Market by End-user and Geography - Forecast and Analysis 2021-2025: The alcohol prep pads market has the potential to grow by USD 194.50 million during 2021-2025, according to Technavio. Download Free Sample

Intravenous Fluid Bags Market 2021-2025: Key Highlights

Table of Contents:

Executive Summary

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation by End-user

Customer landscape

Geographic Landscape

Vendor Landscape

Vendor Analysis

Appendix

Technavio's in-depth market research reports now include a thorough analysis of the COVID-19 impact on various markets to help industry leaders navigate their business through the new normal. Download Latest Free Sample Report 

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....

at 07:10
908 Devices Inc. , a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024. Company management will...

at 07:10
Calidi Biotherapeutics Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to invite investors to a webinar on April 24, 2024 at 4:15 p.m. ET. The exclusive event, hosted by RedChip...

at 07:10
ZYUS Life Sciences Corporation (the "Company") , a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, announced today that the USPTO...

at 07:10
The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis. The Improving Access to Home Dialysis Act (HR-8075) was introduced today in the U.S. House of...

at 07:05
hC Bioscience, a biopharmaceutical company developing a fundamentally novel approach to treating genetic diseases through tRNA-based protein editing, today announced preclinical data supporting its lead program in severe hemophilia A at the World...



News published on and distributed by: